Cyclin-dependent kinases (CDK) regulate the cell cycle, transcription and splicing, and in the last decade these enzymes have different classes of chemical inhibitors. So far, the following types of CDK inhibitors have been well validated: astaxanthin, flavopyridine, butyrolactone purine derivatives, indenurin, paullones, benzimidazolopyrimidine, etc. CDK2 plays an important role in encoding a member of the serine/threonine protein kinases involved in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which efficiently regulates cell cycle progression. In dividing cells, CDK2 is the major cell cycle component controlling the G1/S and S/G2 transitions.
BOC Sciences has designed a CDK2 focused library containing to deliver more than 400 cyclin-dependent kinases 2 compounds.
Figure 1. The role of CDKs at different stages of the cell cycle. (Ukasik, P.; et al. 2021)
BOC Sciences can generate its cyclin-dependent kinase 2 (CDK2) focused library using a receptor-based compound virtual screening approach.
Figure 2. Regulation of transcription initiation and elongation by CDKs. (Ukasik, P.; et al. 2021)
Table1. Physicochemical parameters for the BOC Sciences Pre HTS Compound Library
Parameter | Value |
MW | 150-500 |
Number of Rotatable Bonds | 0-10 |
Number of H Donors | 0-5 |
Number of H Acceptors | 0-9 |
TPSA | 140 |
Number of NO2 groups | 0-2 |
Number of S atoms | 0-1 |
Number of halogen atoms | 0-5 |
Compounds with ‘undesirable’ functionalities | Removed |
BOC Sciences provides professional, rapid and high-quality services of Cyclin-dependent Kinases 2 (CDK2) Focused Library design at competitive prices for global customers. Personalized and customized services of Cyclin-dependent Kinases 2 (CDK2) Focused Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.